Table 1.
Demographic characteristics of the investigated patients.
| Total (n = 53) | Survivor (n = 21) | Nonsurvivor (n = 32) | p | |
|---|---|---|---|---|
| Age, years (mean ± SD) | 47.1 ± 17.3 | 39.6 ± 20.7 | 64.2 ± 13.9 | 0.004 |
| Male (n, %) | 40 (75%) | 15 (71%) | 25 (78%) | 0.307 |
| Comorbidities (n, %) | ||||
| Diabetes mellitus | 19 (35.8%) | 4 (19%) | 15 (46%) | 0.022 |
| Dyslipidemia | 14 (26.4%) | 6 (28.5%) | 8 (25%) | 0.412 |
| Hypertension | 14 (26.4%) | 6 (28.5%) | 8 (25%) | 0.361 |
| Chronic pulmonary disease | 6 (11.3%) | 2 (9.5%) | 4 (12.5%) | 0.284 |
| Chronic renal failure | 2 (3.7%) | 1 (4.7%) | 1 (3.1%) | 0.521 |
| Sepsis origin (n, %) | ||||
| Pulmonary | 31 (58.4%) | 14 (66.5%) | 17 (53%) | 0.491 |
| Abdominal | 1 (1.8%) | 1 (4.7%) | 0 (0%) | |
| Central venous catheter | 3 (5.6%) | 1 (4.7%) | 2 (6.2%) | |
| Urinary tract | 7 (13.2%) | 3 (14.2%) | 4 (12.5%) | |
| Skin and soft tissue | 6 (11.3%) | 2 (9.5%) | 4 (12.5%) | |
| Nonidentified | 5 (9.4%) | 2 (9.5%) | 3 (9.3%) | |
| Septic shock (n, %) | 29 (54.7%) | 7 (33%) | 22 (69%) | 0.012 |
| Thrombotic events (n, %) | 11 (20.75%) | 7 (33%) | 4 (12.5%) | 0.067 |
| Length of stay | 23.13 ± 53 | 17.81 ± 15.7 | 26.74 ± 67.7 | 0.081 |
| SOFA (mean ± SD) | ||||
| Baseline | 16.1 ± 9.1 | 14.8 ± 6.1 | 15.1 ± 7.1 | 0.642 |
| Day 1 | 15.3 ± 7.9 | 10.2 ± 3.9 | 14.7 ± 7.3 | 0.221 |
| Day 3 | 10.1 ± 4.5 | 7.1 ± 2.5 | 13.3 ± 6.4 | 0.001 |
| Day 5 | 7.3 ± 3.9 | 4.3 ± 1.9 | 10.8 ± 5.4 | 0.002 |
| Day 8 | 8.4 ± 2.1 | 8.1 ± 2.7 | 9.1 ± 5.8 | 0.364 |
| Day 10 | 7.9 ± 4.6 | 6.3 ± 1.1 | 8 ± 3.2 | 0.210 |
| Mortality (%) | 60 |
SOFA: Sequential Organ Failure Assessment score; SD: standard deviation.